South & Central America Organoids Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The South & Central America organoids market size is expected to reach US$ 806.23 million by 2031 from US$ 160.44 million in 2023. The market is estimated to record a CAGR of 22.4% from 2023 to 2031.

Executive Summary and South & Central America Organoids Market Analysis:

The South & Central America organoids market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow with the increasing cancer cases, growing government initiatives, and rising organoids R&D.

South & Central America Organoids Market Strategic Insights

Get more information on this report Request Free Sample PDF

South & Central America Organoids Market Segmentation Analysis

Key segments that contributed to the derivation of the South & Central America organoids market analysis are type, application, source, offering, and method.

• Based on type, the South & Central America organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine held the largest share of the market in 2023.
• Based on application, the South & Central America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease held the largest share of the market in 2023.
• Based on source, the South & Central America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells held a larger share of the market in 2023.
• Based on offering, the South & Central America organoids market is segmented into instruments, consumables, and services. The consumables held the largest share of the market in 2023. The instruments segment is further subsegmented into devices and equipment. The consumables segment is further subsegmented into sensors and others.
• Based on method, the South & Central America organoids market is segmented into micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion, and others. The hanging drop held the largest share of the market in 2023.

South & Central America Organoids Market Outlook

Technological advancements enabling the combination of organoids with organ-on-a-chip facilitate various applications in biological and biomedical fields for disease modeling and clinical drug screening. Organoids and organ-on-a-chip, which serve as evolving pathological and human physiological in vitro models, have the potential to revolutionize the conventional paradigm of cancer research and produce real clinical benefits. The recent inclination in the collaborative application of organoids with organ-on-a-chip and 3D bioprinting enables the development of sophisticated cancer models to study underlying mechanisms of tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment interactions. Organoid-on-a-chip, the incorporation of multiple organoids on a chip, exhibits the benefits of both organoid and organ-on-a-chip as well as provides a valuable tool to study multiorgan tumor metastases and cancer-microenvironment interactions.

Technological advancements have enabled the development of brain organoids-on-chip, liver organoids-on-chip, intestine organoids-on-chip, and more. Organoid-on-a-chip is an emerging segment with much scope for improvement. Thus, with cooperative efforts from interdisciplinary researchers to reach the full utility of organoids in human biomedical studies, the combination of organoids and organ-on-a-chip is emerging as a significant trend in the organoids market.

South & Central America Organoids Market Country Insights

Based on country, the South & Central America organoids market comprises Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2023.

According to the Brazilian Transplantation Registry, Brazil conducts the world's second-largest number of kidney and liver transplant programs. However, due to regional disparities, organ donation and allocation systems still need improvement. Factors such as the acceptance of organ donation in the population, fairness of the healthcare systems, supportive government and medical societies, and the availability of dedicated healthcare professionals have resulted in the success of the Brazilian Transplantation Program. As per the Brazilian Association of Organ Transplantation (ABTO), ~53,000 people in Brazil received an organ from a deceased donor by the end of December 2022, which has been the highest number in more than past 20 years. A patient's healthy cells could be made into organoids that help their body repair damaged tissue after transplantation. Thus, the organoids market in Brazil is majorly driven by the rising need for transplants. The ongoing research further empowers organoid development efforts through 3D printing technology in Brazil. Organoids are developed by combining bioengineering techniques, such as cell reprogramming and cultivating pluripotent stem cells with 3D bioprinting.

South & Central America Organoids Market Report Highlights

South & Central America Organoids Market Company Profiles

Some of the key players operating in the market STEMCELL Technologies Inc; Molecular Devices, LLC.; Hubrecht Organoid Technology; Definigen; Organoid Therapeutics; Thermo Fisher Scientific Inc; Corning Inc; Merck KGaA; InSphero; ACRO Biosystems; Bio-Techne Corp; SUN bioscience SA; ORGANOID SCIENCES Co., Ltd.; Crown Bioscience Inc; Sartorius AG; 3D Biotek LLC; Prellis Biologics Inc.; 3Dnamics Inc.; and Cellesce Ltd among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Organoids Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

South & Central America Organoids Market Country and Regional Insights